ALG-1007

N/A

Report date: 2022/07/19 12:08:27
NME

Base Information

Drug NameALG-1007
Drug Alias NameALG-1007
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionIntegrin antagonists
TargetsIntegrin
Therapy Area/IndicationsXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAllegro Ophthalmics Llc
China Registration ClassN/A

Develop Information

Active CompaniesAllegro Ophthalmics Llc
Inactive CompaniesN/A
Active IndicationsXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A